HomeNews

News

News

Pelabresib and Rituxan Combo Improves Outcomes in Myelofibrosis

Editor -
Pelabresib plus Rituxan improved spleen measurement and signs in untreated myelofibrosis, assembly the primary objective of the MANIFEST-2 trial.Pelabresib (CPI-0610) remedy together with...
News

A Journey of Assist and Hope

Editor -
From left: Christine Simonelli, B.S.N., RN, CCRC, OCN, and Tina M. Mason, PH.D., APRN, AOCN, AOCNS, FCNSChristine Simonelli, B.S.N., RN, CCRC, OCN, is...
News

Personalizing Prostate Most cancers Care With Genetic Testing, PARP Inhibitors

Editor -
Dr. Kristen Scarpato explains the position of genetic testing in prostate most cancers care: © inventory.adobe.com.Precision drugs has revolutionized the therapy of prostate...
News

Tracing a 5-Era Most cancers Legacy Via Genetic Discovery

Editor -
Sue McCarthy acquired diagnoses of breast most cancers in 2001 and lung most cancers in 2018. Compensate for all of Sue's blogs right here!My...
News

Patritumab Deruxtecan BLA Withdrawn in Non-Small Cell Lung Most cancers

Editor -
The FDA utility for patritumab deruxtecan in handled EGFR-mutant lung most cancers was withdrawn after confirmatory trial knowledge missed survival objectives.The biologics license...
1...316317318...672Page 317 of 672

Hot Topics

Load more

Quick Links

Must Read

Popular Articles

© 2024 Cancer Care Portal. All rights reserved.